Lipase Reagent Market Size

Lipase Reagent Market size was valued at USD 721.08 billion in 2024 and is likely to cross USD 1.71 trillion by 2037, expanding at more than 6.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of lipase reagent is estimated at USD 802.88 billion.

The growth of the market can be attributed to the increasing number of patients who are suffering from different diseases that require lipase analysis. The lipase testing reagents act as indicators to study the presence of pancreas-related disorders and other gastric problems. The rise in widespread demand for lipase testing reagents on account of indigestion, acute and chronic pancreatic disorders, gastroesophageal reflux disease (GERD). and other intestinal disorders is expected to drive the market growth during the forecast period. The incidence of acute pancreatitis raised from 28 per 100,000 population in 1999 to 36 per 100,000 population in 2010.

In addition to these, factors that are believed to fuel the market growth of Lipase Reagent include the increase in diseases like vitamin deficiency, dehydration, malnutrition, high gastric acids, and persistent diarrhea. As per the Centers for Disease Control and Prevention, the number of adults diagnosed with ulcers was about 14.8 million in 2018.

Besides, the demand for lipase testing reagents market is propelling as children with cystic fibrosis (CF) or Schwachman-Diamond Syndrome (SDS) diagnosis increase. Lipase levels are high in patients with cystic fibrosis. According to the World Gastroenterology Organization, out of 100%, 49% of females and 36.6% of males have the most common disorders like constipation, diarrhea, IBS, proctalgia fungal, and dyspepsia at rates of 11.7%, 4.7%, 4.1%, 5.9%, and 7.2% respectively.